David Lim
Managing Director
Biotechnology
Asiagenomics
Malaysia
Biography
David is co-founder and Managing Director of Raffles Venture Partners since 2008. David led the launch and management of funds that invest into top-tier US-led funds, as well as direct investment and co-investment into Singapore and overseas startups. Exits include Spinal Modulation Inc (acquired by St. Jude Medical), NFocus Neuromedical Inc (acquired by Covidien PLC) and Corous360 (acquired by DeClout SGX 5UZ.SI). David is currently a director or alternate on Asia Genomics Pte Ltd, Knorex Pte Ltd and Gnossem Pte Ltd.
Research Interest
Genomics
